Thank you, Mr. Chair.
I think all of us agree that none of us like wastage, especially of valuable vaccines, but I think it's far better that we err on the side of purchasing too many than not having enough. It's the unnecessary wastage that we want to look at, because I believe Dr. Kochhar indicated that with any vaccination program, because of the process, there is always wastage of vaccines.
We've heard from procurement services what they would do differently and the lessons learned. In all of these report processes, that's always the most important thing: What have we learned going forward?
I'd be interested in hearing from both Dr. Lucas and Dr. Kochhar what their departments have learned from this process and how they'd handle things differently going forward to avoid some of the pitfalls we experienced.